Summary
Whereas substantial evidence indicates that the majority of glioma patients make humoral immune responses to their own tumours, the evidence that glioma patients make significant cellular immune responses is more tenuous and controversial. In order to study those properties of human gliomas that might contribute to their ability to escape cell-mediated immune attack, we have examined the ability of cultured human glioma cells to elicit allogeneic cytolytic lymphocyte responses in vitro. Five of ten glioma lines were unable to elicit allogeneic cytolytic lymphocyte responses in mixed lymphocyte-tumour cultures, despite the presence of serologically detectable alloantigens on the surface of the glioma cells. Analysis of the reasons why certain glioma lines failed to stimulate cytolytic lymphocyte responses revealed three distinct mechanisms by which human gliomas may escape cellular immune attack: 1. a defect in immunogenicity which can be overcome by “help” from an allogeneic mixed lymphocyte reaction, 2. the secretion of a protective mucopolysaccharide coat, and 3. the production of macromolecular immunosuppressive substance(s). The implications of these findings for the immunotherapy of human gliomas are discussed.
Similar content being viewed by others
Abbreviations
- CTL:
-
cytolytic T lymphocyte
- C:
-
complement
- FBS:
-
foetal bovine serum
- MLR:
-
mixed lymphocyte reaction
- MLTC:
-
mixed lymphocyte tumour culture
- NK:
-
natural killer
- PBS:
-
phosphate-buffered saline
- R:
-
responder lymphocyte
- S:
-
stimulator lymphocyte
- TCGF:
-
T cell growth factor
- TCM:
-
tissue culture medium
References
Anderson, D. R., Spencer, W. H., Ultrastructural and histochemical observations of optic nerve gliomas. Arch. Ophthal.83 (1970), 324–335.
Anderson, R. J., McBride, C. M., Hersh, E. M., Lymphocyte blastogenic responses to cultured allogenic tumor cells in vitro. Cancer Res.32 (1972), 988–992.
Apuzzo, M. L. J., Mitchell, M. S., Immunological aspects of intrinsic glial tumors. J. Neurosurg.55 (1981), 1–18.
Arseni, C., Carp, N., Mestes, E., Adel, M., Histochemistry of mucopoly-saccharides in brain tumors. Acta Neuropathol. (Berl.)7 (1967), 275–284.
Bach, F. H., Bach, M. L., Sondel, P. M., Differential function of major histocompatibility complex antigens in T-lymphocyte activation. Nature259 (1976), 273–281.
Bach, F. H., Grillot-Courvalin, C., Kuperman, O. J., Sollinger, H. W., Hayes, C., Sondel, P. M., Alter, B. J., Bach, M. L., Antigenic requirements for triggering of cytotoxic T lymphocytes. Immunol. Rev.35 (1977), 76–96.
Bloom, H. J. G., Peckham, M. J., Richardson, A. E., Alexander, P. A., Payne, P. M., Glioblastoma multiforme: A controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Brit. J. Cancer27 (1973), 253–267.
Bolhuis, R. L. H., Schellekens, H., Induction of natural killer cell activity and allocytotoxicity in human peripheral blood lymphocytes after mixed lymphocyte culture. Scand. J. Immunol.13 (1981), 401–412.
Boyum, A., Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest.21 (Suppl. 97) (1968), 77–89.
Brooks, W. H., Latta, R. B., Mahaley, M. S., Roszman, T. L., Dudka, L., Skaggs, C., Immunobiology of primary intracranial tumors. Part 5: Correlation of a lymphocyte index and clinical status. J. Neurosurg.54 (1981), 331–337.
Brooks, W. H., Netsky, M. G., Normanseil, D. E., Horwitz, D. E., Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J. Exp. Med.136 (1972), 1631–1647.
Goakham, H. B., Kornblith, P. L., Quindlen, E. A., Pollock, L. A., Wood, W. C., Hartnett, L. C., Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays. J. Natl. Cancer Inst.64 (1980), 223–233.
Dohan, F. C., Kornblith, P. L., Wellum, G. R., Pfeiffer, S. F., Levine, L., S-100 protein and 2′, 3′-cyclic nucleotide 3′-phospho-hydrolase in human brain tumors. Acta Neuropathol. (Berl.)40 (1977), 123–128.
Dorfman, A., Ho, P.-L., Synthesis of acid mucopolysaccharides by glial tumor cells in tissue culture. Proc. Natl. Acad. Sci. U.S.A.66 (1970), 495–499.
Drew, S. I., Terasaki, P. I., Billing, R. J., Bergh, O. J., Minowada, J. Klein, E., Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker. Blood49 (1977), 715–718.
Fraser, J. R. E., Clarris, B. J., On the reaction of human synovial cells exposed to homologous leukocytes in vitro. Clin. Exp. Immunol.6 (1970), 211–225.
Friedman, S. M., Neyhard, N., Chess, L., Cell-mediated lympholysis of trinitrophenyl-derivatized autologous human cells: in vitro triggering by nonspecific signals. J. Immunol.120 (1978), 630–637.
Gately, M. K., Glaser, M., Dick, S. J., Mettetal, R. W., Jr., Kornblith, P. L., In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cytolytic T lymphocyte responses to allogeneic cultured gliomas. J. Natl. Cancer Inst. In press.
Gately, M. K., Martz, E., Comparative studies on the mechanisms of nonspecific Con A-dependent cytolysis and specific T cell-mediated cytolysis. J. Immunol.119 (1977), 1711–1722.
Glimelius, B., Norling, B., Westermark, B., Wasteson, A., Composition and distribution of glycosaminoglycans in cultures of human normal and malignant glial cells. Biochem. J.172 (1978), 443–456.
Herberman, R. B., Cell-mediated immunity to tumor cells. Adv. Cancer Res.19 (1974), 207–263.
Kano, I., Friedman, H., Immunosuppression and the role of suppressive factors in cancer. Adv. Cancer Res.25 (1977), 271–321.
Kern, D. E., Gillis, S., Okada, M., Henney, C. S., The role of interleukin-2 IL-2) in the differentiation of cytotoxic T cells: The effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines. J. Immunol.127 (1981), 1323–1328.
Kernohan, J. W., Sayre, G. P., Tumors of the central nervous system. Washington D.C.: Armed Forces Institute of Pathology, 1952.
Kumar, S., Taylor, G., Steward, J. K., Waghe, M. A., Morris-Jones, P., Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system. Int. J. Cancer12 (1973), 194–205.
Lafferty, K. J., Misko, I. S., Cooley, M. A., Allogeneic stimulation modulates the in vitro response of T cells to transplantation antigen. Nature249 (1974), 275–276.
Lee, S. K., Oliver, R. T. D., Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia. J. Exp. Med.147 (1978), 912–922.
Levy, N. L., Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors. J. Immunol.121 (1978), 903–915.
Masucci, M. G., Klein, E., Argov, S., Disappearance of the NK effect after explantation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated cultures. J. Immunol.124 (1980), 2458–2463.
McBride, W. H., Bard, J. B. L., Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis. J. Exp. Med.149 (1979), 507–515.
Ohya, T., Kaneko, T., Novel hyaluronidase from streptomyces. Biochem. Biophys. Acta198 (1970), 607–609.
Okada, M., Klimpel, G. R., Kuppers, R. C., Henney, C. S., The differentiation of cytotoxic T cells in vitro. I. Amplifying factor(s) in the primary response is Lyt 1 + cell dependent. J. Immunol.122 (1979), 2527–2533.
Perper, R. J., Zee, T. W., Mickelson, M. M., Purification of lymphocytes and platelets by gradient centrifugation. J. Lab. Clin. Med.72 (1968), 842–848.
Pfrendschuh, M., Shiku, H., Takahashi, T., Ueda, R., Ransohoff, J., Oettgen, H. F., Old, L. J., Serological analysis of cell surface antigens of malignant human brain tumors. Proc. Nad. Acad. Sci. U.S.A.75 (1978), 5122–5126.
Pontén, J., Neoplastic human glial cells in culture. In: Human tumor cells in vitro (Fogh, J., ed.), pp. 175–206. New York: Plenum Press. 1975.
Röllinghoff, M., Wagner, H., Effect of M-locus dependent T-cell proliferation upon the induction of anti H-2 cytotoxic T effector cells. J. Immunogen. 2 (1975), 301–308.
Seeley, J. K., Masucci, G., Poros, A., Klein, E., Golub, S. H., Studies on cytotoxicity generated in human mixed lymphocyte cultures. II. Anti-K 562 effectors are distinct from allospecific CTL and can be generated from NK-depleted T cells. J. Immunol.123 (1979), 1303–1311.
Sheikh, K. M. A., Apuzzo, M. L. J., Weiss, M. H., Specific cellular immune responses in patients with malignant gliomas. Cancer Res.39 (1979), 1733–1738.
Sondel, P. M., O'Brien, C., Porter, L., Schlossmann, S. F., Chess, L., Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: A requirement for a proliferative triggerin vitro. J. Immunol.117 (1976), 2197–2203.
Sopori, M. L., Alter, B. J., Bach, F. H., Cell-free factor substitute for “signal 2” in generating cytotoxic reactions. Eur. J. Immunol.7 (1977), 823–825.
Trachtenberg, M. C., Kornblith, P. L., Hauptli, J., Biophysical properties of cultured human glial cells. Brain Res.38 (1972), 279–298.
Trouillas, P., Immunologie et immunothérapie des tumeurs cérébrales. Etat Actuel Rev. Neurol.128 (1973), 23–38.
Walker, M. D., Alexander, E., Jr., Hunt, W. E., MacCarty, C. S., Mahaley, M. S., Jr., Mealey, J., Jr., Norrell, H. A., Owens, G., Ransohoff, J., Nilson, C. B., Gehan, E. A., Strike, T. A., Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J. Neurosurg.49 (1978), 333–343.
Weinberger, O., Herrmann, S., Mescher, M. F., Benacerraf, B., Burakoff, S. J., Antigen-presenting cell function in induction of helper T cells for cytotoxic T-lymphocyte responses: Evidence for antigen processing. Proc. Natl. Acad. Sci. U.S.A.78 (1981), 1796–1799.
Weinstein, R. S., Kornblith, P. L., Ultrastructure of a cloned astrocytoma in tissue culture. Cancer27 (1971), 1174–1181.
Whisler, R. L., Yates, A. J., Regulation of lymphocyte responses by human gangliosides. I. Characteristics of inhibitory effects and the induction of impaired activation. J. Immunol.125 (1980), 2106–2111.
Woosley, R. E., Mahaley, M. S., Jr., Mahaley, J. L., Miller, G. M., Brooks, W. H., Immunobiology of primary intracranial tumors. Part 3: Micro-cytotoxicity assays of specific immune responses of brain tumor patients. J. Neurosurg.47 (1977), 871–885.
Young, H. F., Sakalas, R., Kaplan, A. M., Inhibition of cell-mediated immunity in patients with brain tumors. Surg. Neurol.5 (1976), 19–23.
Zarling, J. M., Kung, P. C., Monoclonal antibodies which distinguish between human NK cells and cytotoxic T lymphocytes. Nature288 (1980), 394–396.
Zarling, J. M., Raich, P. C., McKeough, M., Bach, F. H., Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells. Nature262 (1976), 691–693.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gately, M.K., Glaser, M., McCarron, R.M. et al. Mechanisms by which human gliomas may escape cellular immune attack. Acta neurochir 64, 175–197 (1982). https://doi.org/10.1007/BF01406052
Issue Date:
DOI: https://doi.org/10.1007/BF01406052